Daiichi Sankyo
Michele Schmidt currently serves as a Member at Chief, an organization dedicated to empowering women leaders since November 2022. In addition, Michele has held various senior roles at Daiichi Sankyo, Inc. since November 2019, including Head of Asset and Portfolio Management and Vice President of Global Clinical Operations and Planning. Prior to this, Michele spent over a decade at Celgene, where positions included Vice President of Global Project Leadership in Hematology/Oncology and Executive Director of Global Project Leadership. Michele's earlier career includes roles at Pharmacia and academic achievements with a Master of Public Health from Benedictine University and a Bachelor of Science in Nursing from Bloomfield College.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.